Lecture 43 Flashcards
Indirect Acting Agonists
Amphetamines
- CII
- Amphetamine, Dextroamphetamine, Methamphetamine
- Non-catecholaminic sympathomimetic agents
- Stimulates cate. release (displaces from vesicles)
- Inhibits reuptake (completes with cate. pumps)
- Affects NE and DA in CNS and PNS
Adderall
- Onset: 30-60 minutes, half life: 6-10 hours
- Equivalent amount of mixed amphetamine salt combos
- XR: once daily
- Black box: high potential for abuse, can cause sudden death or severe CV reactions
Adderall Uses
- ADHD
- Short-term Obesity
- Narcolepsy
ADHD
- Children: inattention, hyperactive, impulsive
- Adults: lack of organization and motivation
- Genetics: 80% in twin studies
- ADHD with comobid tics (10-35% of patients) may worsen with stimulants
Adderall + ADHD
- Amphetamines improve attention and reduce distractability and impulsiveness
- Avoid giving near bedtime since insomnia and anorexia can occur
- Side effects decrease with time
Adderall + Obesity
- Short term treatment: 3-6 weeks
- Suppresses appetite centers of hypothalamus
- Anorexic effects in the first few weeks (decline with time)
Narcolepsy
- Transition from waking state to REM sleep
- Loses muscle tone (cataplexy), falls to ground, hypnogognic hallucinations
Lisdexamfetamine
-Vyvanse
-Inactive prodrug of dextroamphetamine (covalently bonded to l-lysine)
-Hydrolyzed in intestine/first pass metabolism
-Limits abuse potential when used IV/intranasally
Uses: ADHD, moderate to severe binge eating disorder (FDA approved)
Methamphetamine
- Desoxyn, Methampex
- CII
- Oral
- Uses: ADHD, exogenous obesity (short-term) when in refractory period of alternate therapy
- Black Box: High potential for abuse, use in weight reduction only when other therapies are ineffective, can cause sudden death and severe CV reactions
Methylphenidate
- Ritalin, Concerta, Daytrana
- Dexmethylphenidate: D-enantiomer of methylphenidate (more active)
- Milder peripheral actions
- CII
- Used in ADHD, narcolepsy, and depression or post-stroke depression (off-label)
- *Many sustained release versions available**
Phentermine
- Apidex-P
- Stimlant
- CIV
- Increases NE and DA release, inhibits uptake
- Used for short term obesity with dietary/behavior modifications and exercise
- Use in obese patients with BMI>30 or >27 in the presence of other risk factors
Diethylpropion
- Tenuate
- Similar mechanism to amphetamine
- CIV
- Oral
- Manages exogenous obesity in those not responding to other therapies
Bathsalts
- Crystalline, scented substances added to bath water
- Any of several catecholamine synthesized drugs used as stimulants and usually packages to look like cosmetics or household products
Ephedrine
-Releases endogenous NE indirectly and directly acts on B-receptors
Uses
- Acute bronchospasm
- Hypotension in spinal anesthesia/overdoses of hypotensive causing drugs
- Orthostatic hypotension
- Nasal congestion
Pseudophedrine
- Sudafed
- OTC, oral
- Indirect and direct effects on alpha receptors
- Treats nasal congestion (Cold and allergies) and prophylaxis for otitic barotrauma in air pressure changes
- *Combat Methamphetamine Epidemic Act of 2005**
Nexafed
- New Sudafed drug to curb meth production
- Turns into thick gel when dissolved, makes Sudafed hader to extract
Cocaine
- CII, high abuse potential
- Euphoria
- Reuptake inhibitor of NE, DA, 5-HT (indirect agonist)
- General sympathetic effect: increases HR/BP
- Local anesthetic on mucous membranes or in oral, laryngeal, and nasal cavities
- Vasoconstrictor action that decreases bleeding
Stimulant Contraindications
- High potential for abuse, less so for CIV
- Not recommended for those with substance abuse problems
- Do not use in those with cardiac disease, hyperthyroidism, psychosis, and depression
Drug Interactions with Stimulants
- Enhances other sympathomimetics (CNS and PNS)
- MAOIs, caution with L-DOPA
- May counteract some antihypertensive agents
- Antipsychotic drugs (D2 agonists) may block central stimulant action and decrease affects of drugs used for ADHD, narcolepsy, and appetite suppression
Stimulant Adverse Reactions
- Anxiety, headache, insomnia (lower doses or take drug holidays to reduce these)
- High doses/overdoses: paranoia, psychosis, arrhythmias, seizures, coma, and death
- Growth inhibition in children due to decreased appetite and altered GH secretion
- CV: increased BP/HR
- Reverse tolerance (sensitization)
- Severe depressive symptoms, anxiety, and suicidal idealation
* *During D/C, monitor patient and gradually reduce dose to minimize these effects**
Modafinil
- Provigil
- Alternative narcolepsy treatment option
- CIV, low abuse potential
- Stimulant
- R isomer (active) = Armodafinil
- Minimal peripheral side effects, no tolerance development
- Improves wakeful-ness in those with narcolepsy, obstructive sleep apnea, and shift work disorder
- *Doesn’t cause agitation, aggression, etc.**
Atomoxetime
- Strattera
- Treats ADHD in adults and children by blocking NE reuptake
- Doesn’t exacerbate tics
- Original two trials saw a 59-64% response when compared to the placebo
- Side effect: suppressed appetite
- Lacks abuse potential, so good for those with abuse history
Drugs Removed from Market
- Phenylpropanolamine - D/C 2000, stroke
- Pemoline (Cylert) - D/C 2005, life threatening hepatic failure
- Sibutramine (Merdine) - D/C 2010, increased CV risks
Drugs NOT to use with LQTS
- Amphetamine/dextroamphetamine (Adderall, Adderall XR)
- Dextroamphetamine (Dexedrine)
- Methamphetamine
- Methylphenidate (Ritalin, Concerta)
- Dexmethylphenidate (Focalin)
- Lisdexamfetamine (Vyvanse)
- Atomoxetine (Strattera)